Back to Home
Video

Empowering Breast Cancer Patients with Non-Opioid Pain Management Innovations

Release Date

March 29, 2024

Expiration Date

March 30, 2025

Credits

1.5 CME

Specialties

Breast Cancer, Medical Oncology+2 more

Release Date: March 29, 2024

Expiration Date: March 29, 2025

Activity Overview

This online, on-demand virtual symposium brings together renowned experts in breast cancer. In this educational program, these experts explore options for the proactive management of pain for patients with breast cancer as well as associated adverse events with both opioid analgesics and non-opioid strategies.

This educational activity is an archive of the live symposium held on March 7, 2024.

Target Audience

The live educational program is directed toward medical oncologists, surgical oncologists, radiation oncologists, nurse practitioners, physician assistants, nurses, and other health care professionals involved in the treatment of breast cancer.

Learning Objectives

Upon successful completion of this activity, you should be better prepared to:

  • Examine the clinical implications of methods to reduce opioid usage in managing perioperative and postoperative pain in breast cancer care settings
  • Develop collaborative and multidisciplinary pain management protocols that incorporate techniques informed by current clinical insights
  • Explain evidence on the efficacy of preemptive multimodal pain control and their impact on breast cancer outcomes
  • Implement optimized pain management protocols to facilitate postsurgical care for breast cancer patients
Empowering Breast Cancer Patients with Non-Opioid Pain Management Innovations

GET STARTED WITH THIS PROGRAM:

Register now to gain access to this program.

Create AccountAlready Registered? Login Here

Accreditation/Credit Designation

Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Acknowledgment of Commercial Support

This activity is supported by an educational grant from Pacira Pharmaceuticals, Inc.

Course

Empowering Breast Cancer Patients with Non-Opioid Pain Management Innovations

Create Account